谷歌浏览器插件
订阅小程序
在清言上使用

Immunogenicity of Recurrent Mutations in MYD88 and EZH2 in Non-Hodgkin Lymphomas

Journal for immunotherapy of cancer(2015)

引用 0|浏览41
暂无评分
摘要
Meeting abstracts A fundamental challenge in cancer genomics is to design effective, personalized treatments based on the mutational profiles of tumors. Pharmacological targeting of the numerous aberrant pathways found in individual tumors remains exceedingly challenging, but T cell-based therapies
更多
查看译文
关键词
Lymphoma Patient,Peptide Library,Driver Mutation,Recurrent Mutation,Mutational Profile
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要